Table 2:
Reference | Induction compounds | Expansion phase |
Final maturation factors |
Protocol length (days) |
---|---|---|---|---|
(Shi et al., 2012) Used later in (Dafinca et al., 2016) | Dorsomorphin (10 uM) SB (10 uM) N2, B27 | Neurospheres | - | 80 |
(Almeida et al., 2013) Used later in (Lopez-Gonzalez et al., 2016; Lopez-Gonzalez et al., 2019; Maor-Nof et al., 2021) | bFGF, N2, B27 | Neurospheres | BDNF, GDNF | 72 |
(Bilican et al., 2012) (Livesey et al., 2014) Used later in (Selvaraj et al., 2018) | N2, B27, Forskolin (10 μM) | Monolayer | BDNF, GDNF | 56 |